Výsledky vyhledávání - "Jill Shwed Mccollam"

Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan

Autor: Emily Edson-Heredia, Yoshitaka Isaka, Natalie V. J. Aldhouse, Hitoe Torisu-Itakura, Helen Kitchen, Russel Burge, Jake Macey, Jill Shwed McCollam

Publikováno v: Dermatology and Therapy

Introduction The content validity and treatment success thresholds of clinical outcome assessments (COAs) for alopecia areata (AA)—including the Alopecia Areata-Investigator Global Assessment™ (AA-IGA™), Scalp Hair Assessment Patient-Reported O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7562594d7227c4eee1ca9735b85989bf
http://europepmc.org/articles/PMC8019002

Zobrazit plný text záznamu

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Autor: Manabu Ohyama, Brett A. King, Guanglei Yu, Margaret Gamalo, Yves Dutronc, Jill Shwed McCollam, Justin M. Ko, Emily Edson-Heredia, Katrin Holzwarth, Seth Forman, Natasha Atanaskova Mesinkovska, Jonathan Janes

Publikováno v: Journal of the American Academy of Dermatology. 85(4)

Background There are no treatments approved by the Food and Drug Administration for alopecia areata. Objective To evaluate the efficacy and safety of baricitinib in patients with ≥50% scalp hair loss in a phase 2 study of adults with alopecia areat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffac2677b2b47d798de6e90348532fab
https://pubmed.ncbi.nlm.nih.gov/34090959

Zobrazit plný text záznamu

Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: A prospective, randomized comparison

Autor: T. Byrne, Michael O’Neil, E. Norcross, Scott Reeves, Jill Shwed Mccollam

Publikováno v: Critical Care Medicine. 27:2454-2458

To compare the efficacy, safety, and cost of continuous infusions of lorazepam, midazolam, and propofol in a critically ill trauma/surgery patient population.A prospective, randomized, nonblinded, single center.A 16-bed intensive care unit.A total of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4d6550b784dd55d8bfda13d7fd2675
https://doi.org/10.1097/00003246-199911000-00022

Zobrazit plný text záznamu

Recognizing and managing severe sepsis: a common and deadly threat

Autor: Jill Shwed McCollam, Douglas E Schlichting

Publikováno v: Southern medical journal. 100(6)

Through a literature review, the epidemiology and pathophysiology, including alterations in inflammation, coagulation, and impaired fibrinolysis that occur in the course of severe sepsis, is presented. Treatment guidelines that are evidence-based and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3e8f3c755a5d1bdf4cedbb53bec7c2f
https://pubmed.ncbi.nlm.nih.gov/17591313

Zobrazit plný text záznamu

Static and dynamic assessment of biomarkers in surgical patients with severe sepsis

Autor: Henri R. Ford, Rebecca L. Qualy, Stephen F. Lowry, Donald E. Fry, Becky Bates, Mark D. Williams, Samir S. Awad, William G. Cheadle, Jill Shwed McCollam

Publikováno v: Surgical infections. 5(3)

Severe sepsis, defined as a systemic inflammatory response to infection associated with acute organ dysfunction, is common among surgical patients and is a major cause of morbidity and mortality. Severe sepsis has been associated with changes in infl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3bbc1877159b8b392a3455a4a70f924
https://pubmed.ncbi.nlm.nih.gov/15684797

Zobrazit plný text záznamu

Safety of drotrecogin alfa (activated) in surgical patients with severe sepsis

Autor: Becky Bates, Donald E. Fry, George H. Rodman, Mark D. Williams, Jill Shwed McCollam, Frank V. Booth, Gregory J. Beilman, Stephen F. Lowry, Steven B. Johnson

Publikováno v: Surgical infections. 5(3)

We conducted a retrospective evaluation of the overall safety of drotrecogin alfa (activated) in surgical patients with severe sepsis enrolled in PROWESS.A blinded Surgical Evaluation Committee (SEC) verified surgical patients as having undergone a s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6f374cc8f6458ebc780cb46d098ed5
https://pubmed.ncbi.nlm.nih.gov/15684796

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání